The MPCCC Precision Oncology Program welcomed two eminent speakers in August and September 2019 to present at Precision Oncology Seminars. These seminars brought together researchers [...]
On Tuesday 3 September 2019, 185 guests gathered for an evening of networking, canapes and dinner at Huntingdale Golf Club. MPCCC’s 2019 Cancer Forum attendees [...]
On 21-23 August 2019, The Australian Gastro-intestinal Trials Group (AGITG) held their Annual Scientific Meeting. Dr Simon Wilkins, a Senior Research Fellow at the Cabrini [...]
Two complementary pilot projects will serve as vital foundation work for the implementation of Patient-Reported Outcome Measures (PROMs) and Patient-Reported Experience Measures (PREMs) across MPCCC [...]
Latrobe Regional Hospital (LRH) is in the process of activating its first ever oncology clinical trial, thanks to the MPCCC's Monash-Gippsland Teletrials (MGTT) project. The [...]
Since its commencement in September 2018, the MPCCC Precision Oncology Program has established regular Molecular Tumour Board meetings that focus on three distinct tumour streams. [...]
As MPCCC’s pilot of shared-care for cancer related depression approaches completion, participants will be invited to evaluate the feasibility of the model and its potential [...]
Outcomes of the Australian-led landmark clinical trial, ENZAMET, are expected to influence clinical practice around the world for men with advanced metastatic prostate cancer. The [...]
Research projects have the potential to improve health services and outcomes for patients, but effectively engaging consumers and the community can enhance research and translation [...]
Professor Melissa Southey has been appointed as the Research Director of the Monash Partners Comprehensive Cancer Consortium (MPCCC) following the resignation of Prof Gail Risbridger [...]
